webinar register page

Webinar banner
Update on Therapeutic Advances in T-Cell Lymphoma
T-cell lymphoma is a rare but deadly hematologic malignancy that is difficult to diagnose and has limited treatment options. Join us for this 2021 update to gain expert perspectives on:
- Differential diagnosis
- Clinical studies supporting the efficacy and safety of novel agents
- Emerging combination and sequential treatment strategies

In addition, our expert faculty provide evidence-based advice regarding:
- Tailoring treatment plans to individual patients
- Managing treatment-related adverse events
- Applying best practices for supportive care and patient safety
- And much more!

Mar 15, 2021 03:00 PM in Eastern Time (US and Canada)

Webinar logo
* Required information

By registering, I agree to the Privacy Statement and Terms of Service.



Steven M. Horwitz, MD
Member and Attending Physician @Memorial Sloan Kettering Cancer Center
Dr. Horwitz is a Member and Attending Physician in the Department of Medicine at Memorial Sloan-Kettering Cancer Center. He is a global leader in both physician and patient education on the topic of cutaneous T-cell lymphoma. Dr. Horwitz is a member of the American Society of Clinical Oncology, the American Society of Hematology, and the International Society of Cutaneous Lymphoma.